Bombay High Court Denies 26‑Week Abortions Citing Insufficient Medical Evidence

The concrete rupture unfolded when a panel of judges at the Bombay High Court dismissed a petition filed by a women’s rights group seeking to expand the legal window for medical termination of pregnancy to 26 weeks in the absence of a specific maternal health risk. The court’s order emphasized that the Medical Termination of Pregnancy Act requires a clear medical indication, and that extending the gestational limit without such evidence would contravene statutory safeguards. The decision was rendered after hearing testimonies from obstetricians who argued that late‑term procedures carry heightened complications, and from legal scholars who warned of potential misuse.

Underlying tension now lies in the clash between public health considerations and the broader movement for reproductive autonomy. Advocacy organisations have decried the judgment as a setback for women facing fetal anomalies or severe health concerns that manifest later in pregnancy, while conservative factions applaud the reinforcement of existing safeguards. The ruling also spotlights the divergent interpretations of medical evidence across state health departments, prompting calls for a uniform national guideline that reconciles clinical realities with legal frameworks. In Maharashtra, the health ministry has signalled a review of its protocols, fearing that the judgment may influence future litigation and policy formulation.

The downstream casualties manifest in delayed access to safe termination services for women whose medical circumstances emerge beyond the 20‑week threshold, potentially driving them toward unsafe alternatives. Hospitals report an uptick in requests for case‑by‑case approvals, straining administrative resources and creating uncertainty for both patients and providers. Legal analysts forecast that the decision may inspire similar challenges in other high courts, prompting a cascade of judicial scrutiny that could either solidify the current gestational limits or, conversely, catalyse legislative amendment to address emerging medical complexities.